Market Closed -
Other stock markets
|
After market 03:37:21 am | |||
160.4 USD | -1.29% | 161.4 | +0.62% |
08/05 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
08/05 | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.54% | 283B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+15.70% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B | |
-1.81% | 160B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie, Genmab Lymphoma Treatment Receives Priority Review by FDA for New Indication